Related references
Note: Only part of the references are listed.Acute myotonic reaction during succinylcholine anaesthesia
Saeed Rashaad Mohammed et al.
PRACTICAL NEUROLOGY (2023)
Childbirth with epidural analgesia in a pregnant woman with hypokalemic periodic paralysis
J. Talavan Serna et al.
REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION (2022)
Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity
Vinojini Vivekanandam et al.
BRAIN (2022)
The long exercise test as a functional marker of periodic paralysis
Ana Ribeiro et al.
MUSCLE & NERVE (2022)
Accelerating the genetic diagnosis of neurological disorders presenting with episodic apnoea in infancy
Bryony Silksmith et al.
LANCET CHILD & ADOLESCENT HEALTH (2022)
European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders
Luuk R. van den Bersselaar et al.
EUROPEAN JOURNAL OF NEUROLOGY (2022)
Case report: Novel SCN4A variant associated with a severe congenital myasthenic syndrome/myopathy phenotype
Veronika M. Berghold et al.
FRONTIERS IN PEDIATRICS (2022)
Andersen-Tawil Syndrome A Comprehensive Review
Andres Ricardo Perez-Riera et al.
CARDIOLOGY IN REVIEW (2021)
Skeletal muscle channelopathies: a guide to diagnosis and management
Emma Matthews et al.
PRACTICAL NEUROLOGY (2021)
Thyrotoxic periodic paralysis in an adolescent male: A case report and literature review
Luke He et al.
CLINICAL CASE REPORTS (2021)
Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome
Stefano Maffe et al.
JOURNAL OF ELECTROCARDIOLOGY (2020)
Myotonic Myopathy With Secondary Joint and Skeletal Anomalies From the c.2386C>G, p.L769V Mutation in SCN4A
Nathaniel Elia et al.
FRONTIERS IN NEUROLOGY (2020)
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1
Andrea Mazzanti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Homozygous C-terminal loss-of-function NaV1.4 variant in a patient with congenital myasthenic syndrome
Andoni Echaniz-Laguna et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Acetazolamide can improve symptoms and signs in ion channel-related congenital myopathy
Emma Matthews et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Myasthenic congenital myopathy from recessive mutations at a single residue in NaV1.4
Nathaniel Elia et al.
NEUROLOGY (2019)
A Case of Gitelman Syndrome that Was Difficult to Distinguish from Hypokalemic Periodic Paralysis Caused by Graves' Disease
Takeshi Oba et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2019)
Novel Mutations in SCN4A Gene Cause Myotonia Congenita with Scoliosis
Yang-Qi Xu et al.
CHINESE MEDICAL JOURNAL (2018)
Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands
B. C. Stunnenberg et al.
NEUROMUSCULAR DISORDERS (2018)
Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials
Bas C. Stunnenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy
Vanessa Schartner et al.
ACTA NEUROPATHOLOGICA (2017)
Skeletal Muscle Channelopathies: Rare Disorders with Common Pediatric Symptoms
Emma Matthews et al.
JOURNAL OF PEDIATRICS (2017)
The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study
Grete Andersen et al.
BRAIN (2017)
Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy
Irina T. Zaharieva et al.
BRAIN (2016)
A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis
Karima Habbout et al.
NEUROLOGY (2016)
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis
Valeria A. Sansone et al.
NEUROLOGY (2016)
Flecainide-Responsive Myotonia Permanens With SNEL Onset: A New Case and Literature Review
Simona Portaro et al.
PEDIATRICS (2016)
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
Paola Imbrici et al.
FRONTIERS IN PHARMACOLOGY (2016)
SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype
E. Bugiardini et al.
NEUROMUSCULAR DISORDERS (2015)
ANDERSEN-TAWIL SYNDROME: REPORT OF 3 NOVEL MUTATIONS AND HIGH RISK OF SYMPTOMATIC CARDIAC INVOLVEMENT
Anna Kostera-Pruszczyk et al.
MUSCLE & NERVE (2015)
Channelopathies of Skeletal Muscle Excitability
Stephen C. Cannon
COMPREHENSIVE PHYSIOLOGY (2015)
Coexistence of DMPK gene expansion and CLCN1 missense mutation in the same patient
Charles D. Kassardjian et al.
NEUROGENETICS (2014)
Prevalence study of genetically defined skeletal muscle channelopathies in England
Alejandro Horga et al.
NEUROLOGY (2013)
Severe neonatal episodic laryngospasm due to de novo SCN4A mutations A new treatable disorder
L. Lion-Francois et al.
NEUROLOGY (2010)
Severe neonatal non-dystrophic myotonia secondary to a novel mutation of the voltage-gated sodium channel (SCN4A) gene
Sebastien Gay et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia
Jeroen Trip et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
NEONATAL HYPOTONIA CAN BE A SODIUM CHANNELOPATHY: RECOGNITION OF A NEW PHENOTYPE
E. Matthews et al.
NEUROLOGY (2008)
Electromyography guides toward subgroups of mutations in muscle channelopathies
E Fournier et al.
ANNALS OF NEUROLOGY (2004)
Myasthenic syndrome caused by mutation of the SCN4A sodium channel
A Tsujino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hypokalemic periodic paralysis associated with malignant hyperthermia
YA Rajabally et al.
MUSCLE & NERVE (2002)
Share Paper
